Aktiesnakken — Juli 2020
-
stroenterologi ( mave-tarmsygdomme , red.)
- Efter dagens FDA-godkendelse vil vi nu opsøge vores kunder for at arrangere produktdemonstrationer, sætte evalueringer i gang og markedsføre, hvad Ambu har at tilbyde inden for GI-området, siger Greg Swanson, der er markedsføringsdirektør hos selskabet, i meddelelsen.
Duodenoskopet, der går under navnet Ascope Duodeno, bruges til kikkertundersøgelser via spiserøret af eksempelvis galdeblære og bugspytkirtel.
Ambu har flere gange fortalt, at det reg
-
nede med at kunne lancere duodenoskopet i USA tidligt i medicoselskabets skæve regnskabsårs fjerde kvartal, som løber fra juli til udgangen af september. Den plan ser dermed ud til at holde.
Det danske selskabs løsning består både af selve duodenoskopet, som er til engangsbrug, og en genanvendelig processorløsning. Godkendelsen fra FDA omfatter begge komponenter.
Ambus duodenoskop er modsat de fleste tidligere udgaver fra konkurrenter kun er beregnet til at blive brugt én gang.
Dermed skal de
-
r ikke bruges tid på at rense og rengøre produkterne, ligesom det også kan være med til at reducere smittefaren, som tidligere har vist sig at være højere end ventet for de genanvendelige duodenoskoper.
Ambu gennemførte en mindre test af produktet som et led i godkendelsesprocessen. Testen blev udført blandt 13 gastroenterologer, der evaluerede duodenoskopet.
- Ascope Duodeno præsterede på linje med markedsledende genanvendelige duodenoskoper og blev evalueret positivt, når det kom til billedk
-
billedkvalitet, navigation og ergonomi, skriver Ambu.
Medicoselskabet vil nu som planlagt sætte gang i et post market-studie, der involverer 500 patienter, flere steder i USA.
/ritzau/FINANS
Cecilie Veile
-
Servicemeddelelse. Der kan forekomme enkelte udfald på websiden i nat og i løbet af weekenden. Vi arbejder med ændringer og opdateringer. God weekend.
-
Dow jones gikk ned 0,23 prosent
S&P steg 0,29 prosent
Nasdag gikk opp 0,28 prosent -
Rasbom..Spørg i biotekchatten.
-
WSJ:
The White House economic team faces a key test as negotiations begin with Congress over extending emergency relief measures for the pandemichttps://www.wsj.com/articles/depleted-trump-economic-team-faces-major-test-over-extending-coronavirus-relief-efforts-11595073600?mod=e2twp -
Bloomberg
@business
·
18 min
Japan’s government will start paying its companies to move factories out of Chinahttps://www.bloomberg.com/news/articles/2020-07-18/japan-to-pay-at-least-536-million-for-companies-to-leave-china?utm_campaign=socialflow-organic&utm_content=business&utm_medium=social&utm_source=twitter&cmpid=socialflow-twitter-business -
Bloomberg Markets
@markets
·
6 min
Rising volatility with U.S. stocks near record highs has created opportunities for options investorshttps://www.bloomberg.com/news/articles/2020-07-18/options-traders-bet-on-tighter-trading-ranges-as-earnings-loom?cmpid=socialflow-twitter-business&utm_medium=social&utm_campaign=socialflow-organic&utm_content=markets&utm_source=twitter&cmpid%3D=socialflow-twitter-markets&__twitter_impression=true&sref=UqeAE4Bb -
Mark B. Spiegel
@markbspiegel
·
2 t
"It’s time for investors to stop buying stocks that are ‘stunningly decoupled’ from reality, economist warns"https://www.marketwatch.com/story/its-time-for-investors-to-stop-buying-stocks-that-are-stunningly-decoupled-from-reality-economist-warns-2020-07-14?reflink=mw_share_twitter -
Bloomberg
@business
·
30 min
Oxford’s Covid-19 vaccine, devised by Sarah Gilbert, is in human trials. AstraZeneca has lined up agreements to produce 2 billion doses. Now the world waits https://trib.al/wwyjHOC -
God morgen.
-
Holger Zschaepitz
@Schuldensuehner
·
1 m
Good morning from #Italy, which is obviously not coping so well w/Euro. Since introduction of single currency, country is growing much more slowly than Germany or Spain in terms of per capita income. Before monetary union, Italy was able to keep pace thanks to Lira devaluationshttps://twitter.com/Schuldensuehner/status/1284714080180350976/photo/1 -
Finance News @ftfinancenews
A new sell signal? Stocks underperform after pay revolt, says UBS https://on.ft.com/2CqwMHR -
zerohedge @zerohedge
Global Times' Editor-In-Chief Answers If "There Will Be A War Between China And The US" https://www.zerohedge.com/markets/global-times-editor-chief-answers-if-there-will-be-war-between-china-and-us … -
FactSet @FactSet
$SPX is reporting a decline in revenue of -10.5% for Q2, which would be the largest revenue decline reported by the index since Q3 2009 (-11.5%). https://bit.ly/2ZEhhoE -
Goldman Sachs @GoldmanSachs
"For me, this quarter was about Goldman Sachs demonstrating a lot of grit. It was a very gritty performance." - Jim Esposito of $GS' Global Markets Division: https://click.gs.com/bjnf
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind